← All signals
Signal

Metri.Bio raises $5M pre-seed for endometrial disease therapies

Category
Fertility · Funding · USA
Date
December 3, 2025 · By OVUM Editorial
Source
Company announcement

Summary

Metri.Bio raises $5M pre-seed for endometrial disease therapies. Reported by Company announcement on December 3, 2025. Filed under Fertility · USA.

metri-bio works in women's health, and this round at Pre-seed ($5M) is new money into that part of the market. Compare it with other recent rounds in USA to see whether prices here are rising or holding steady.

OVUM interpretation layer

The editorial read on this signal — pattern, market-structure implications, and what to watch next.

Sources

    The OVUM Intelligence Brief

    Keep reading past this page

    The week's funding, launches, and studies in women's health, in plain English.

    Weekly. No spam. Unsubscribe anytime.